Delivery Order SPE2DB22D2007-SPE2DB25FJ3PZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,306.80 delivery order on August 5, 2025, for BOTOX 100 Unit Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price contract is unclassified as a set-aside and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,011.25 for 200-unit vials of BOTOX on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $3,613.50 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox under a firm fixed-price contract. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a direct procurement of this pharmaceutical product to support federal medical supply needs. This award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $12,821.85 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed price contract, with an ultimate completion date of August 14, 2025, represents a direct procurement of the pharmaceutical product without set-aside designation. The award was issued on July 24, 2025, with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3PZDelivery Order
The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. This delivery order demonstrates AmerisourceBergen's established capability to fulfill specialized medical supply requirements through the DLA Medical Supply Chain. The contract carries no set-aside designation and was competitively awarded, reflecting the company's ability to meet federal procurement standards. As a major pharmaceutical distributor supporting the Defense Health Agency and related government healthcare systems, AmerisourceBergen continues to provide essential medical commodities across multiple therapeutic domains through its flexible IDC vehicle, which enables rapid procurement of varied pharmaceutical products to meet military and federal healthcare demands.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 8/4/25 |